Controversy over early Alzheimer's diagnosis

Can definitive conclusions be drawn about the development of later dementia from early diagnostic findings? If so, are there any medications that actually work for this? In the digiDEM Bayern Science Watch LIVE webinar on Tuesday, June 6, 2023, physician and health services researcher Prof. Dr. med. Elmar Gräßel will report on the controversially debated topic of early Alzheimer's diagnosis. He is the…

Webinar: The Controversy Surrounding Early Alzheimer's Diagnosis 

Even before dementia occurs, biological changes in the brain can be detected early on. These include, for example, protein deposits known as beta-amyloid proteins. These can be detected using cerebrospinal fluid examinations or specialized imaging techniques. Can these findings lead to reliable conclusions about the development of a…

Controversy over new Alzheimer's drug

A new drug has been approved in the US, sparking a global controversy within Alzheimer's research. This is because 10 out of 11 reviewers rejected the drug for the treatment of Alzheimer's disease. The dementia group of the Cochrane Institute provides a brief overview of the evidence for Aducanumab. For a long time, there was...